RARX - Ra Pharmaceuticals Inc

Exchange: NASDAQ

RARX - Ra Pharmaceuticals Inc

Exchange: NASDAQ

Tue 18'th Sep 2018

PERIOD 2018-06-19 - 2018-09-18
CHANGE 7.15%
PRICE $14.08





Request Prediction

Ra Pharmaceuticals Inc Stock Analysis

Technical stock analysis for Tue 18'th Sep 2018

Buy candidate since 2018-08-28 Gain 26.85%
Shorts 4.77% ( 2018-08-31 )
Cash 84.1 mill
Loans n/a
Beta 1.73
ROA -59.29

Ra Pharmaceuticals Inc gained 7.15% in the last trading day, rising from $13.14 to $14.08 , and has now gained 5 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has risen in 7 of the last 10 days and is up by 17.53% over the past 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 181 805 more shares were traded than the day before. In total, 392 592 shares bought and sold for approximately $5.53 million.


Ra Pharmaceuticals Inc has broken the very wide and strong rising the short-term trend up and an even stronger rising rate is indicated. For any reaction back there will now be support on the roof on the current trend broken at $13.87, a level that may pose a second chance to hit a runner. According to fan-theory $17.55 will be the next possible trend-top level and thereby pose a resistance level which may not be broken at the first attempt.

Click here for today's Top 5 Trending Companies


Only positive signals in the chart today. Ra Pharmaceuticals Inc holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $12.88 and $11.32. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday August 20, 2018, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 87 and the stock is extremely overbought on RSI14, but may also ontinue to gain. Some stocks see their best performance while being overbought, but very seldom does RSI remain so high for a long time without short corrections. Risk has therefore increased and larger daily movements can be expected for the next couple of days.

Access full RSI 14 and RSI 21 lists

Support & Resistance

On the downside, the stock finds support just below today's level from accumulated volume at $12.20 and $11.16.

There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Ra Pharmaceuticals Inc finds support just below today's level at $12.20. If this is broken, then the next support from accumulated volume will be at $11.16 and $11.14.

Support: $12.20 Price: $14.08


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.33 between high and low, or 10.37%. For the last week, the stock has had a daily average volatility of 5.21%.

The stock is extremely overbought on RSI14 (87). Normally this will pose a good selling opportunity, but since the stock has broken the trend up the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.

Our recommended stoploss: $13.22 (-6.10%) (This stock has medium daily movements and this gives medium risk. The RSI14 is 87 and this increases the risk substantially. There is a buy signal from pivot bottom found 20 days ago.)

Overall risk:

Very Low Low Medium High Very High


Ra Pharmaceuticals Inc holds several positive signals and has broken the strong rising trend up. As the stock is also in great technical shape, we therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.

Strong Buy Candidate

Click for Top 5 Strong Buy Candidates
RARX $14.08 $0.94(7.15%)
RARX is up $0.94 today, but where's it headed in October?
Zacks Investment Research is releasing its prediction for RARX based on the 1-3 month system that more than doubles the S&P 500.

Click here – the RARX analysis is free »

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Proudly made at

in partnership with